IMMUNE ONCIA THERAPEUTICS INC. Trademark
Trademark Overview
On Tuesday, December 31, 2024, a trademark application was filed for IMMUNE ONCIA THERAPEUTICS INC. with the United States Patent and Trademark Office. The USPTO has given the IMMUNE ONCIA THERAPEUTICS INC. trademark a serial number of 79422542. The federal status of this trademark filing is NON-FINAL ACTION COUNTED - NOT MAILED as of Tuesday, June 17, 2025. This trademark is owned by ImmuneOncia Therapeutics, Inc.. The IMMUNE ONCIA THERAPEUTICS INC. trademark is filed in the Computer & Software Services & Scientific Services category with the following description:
Scientific research for medical purposes in the field of cancerous diseases; scientific research for medical purposes in the area of cancerous diseases; research and development of vaccines and medicines; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; pharmaceutical research and development; medical laboratory services; providing information on the testing, inspection and research of medical products; pharmaceutical product evaluation; engineering services in the medical technology; medical research; drug discovery services; research and development of new products for others; chemical laboratory services; biotechnology research; technical consultancy in relation to research services relating to foods and dietary supplements.
General Information
| Serial Number | 79422542 |
| Word Mark | IMMUNE ONCIA THERAPEUTICS INC. |
| Filing Date | Tuesday, December 31, 2024 |
| Status | 640 - NON-FINAL ACTION COUNTED - NOT MAILED |
| Status Date | Tuesday, June 17, 2025 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s) |
| Published for Opposition Date | NOT AVAILABLE |
Trademark Statements
| Pseudo Mark | IMMUNE ONCIA THERAPEUTICS INC |
| Goods and Services | Scientific research for medical purposes in the field of cancerous diseases; scientific research for medical purposes in the area of cancerous diseases; research and development of vaccines and medicines; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; pharmaceutical research and development; medical laboratory services; providing information on the testing, inspection and research of medical products; pharmaceutical product evaluation; engineering services in the medical technology; medical research; drug discovery services; research and development of new products for others; chemical laboratory services; biotechnology research; technical consultancy in relation to research services relating to foods and dietary supplements. |
Classification Information
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, April 24, 2025 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
Trademark Owner History
| Party Name | ImmuneOncia Therapeutics, Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | KR |
Trademark Events
| Event Date | Event Description |
| Thursday, April 24, 2025 | SN ASSIGNED FOR SECT 66A APPL FROM IB |
| Thursday, June 12, 2025 | ASSIGNED TO EXAMINER |
| Monday, April 28, 2025 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Monday, April 28, 2025 | APPLICATION FILING RECEIPT MAILED |
| Tuesday, June 17, 2025 | NON-FINAL ACTION WRITTEN |
| Wednesday, June 18, 2025 | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW |
